72 related articles for article (PubMed ID: 4119093)
1. [New plasma derivatives].
Soulier JP
Rev Prat; 1972 Mar; 22(9):1465-6 passim. PubMed ID: 4119093
[No Abstract] [Full Text] [Related]
2. Seminar on care of the newborn. IV. Newborn hematologic problems.
Pullen J; Smith R
J Miss State Med Assoc; 1970 Oct; 11(10):543-7 passim. PubMed ID: 4196128
[No Abstract] [Full Text] [Related]
3. [Guidelines for the treatment of hemophilia].
Meili EO; Blättler W; Jacky E; Schneider W; Kaufmann L; Sigg P; Frick PG
Ther Umsch; 1979 Apr; 36(4):345-58. PubMed ID: 313084
[No Abstract] [Full Text] [Related]
4. Clinical uses of human blood fractions.
Schiff P
Med J Aust; 1973 Jan; 1(1):22-6. PubMed ID: 4686436
[No Abstract] [Full Text] [Related]
5. Uses of blood and of blood components.
Med Lett Drugs Ther; 1972 Nov; 14(24):89-92. PubMed ID: 4648571
[No Abstract] [Full Text] [Related]
6. Surgery in haemophilic patients with inhibitors.
Rodriguez-Merchan EC
Haemophilia; 2004 Sep; 10 Suppl 2():1-2. PubMed ID: 15385039
[No Abstract] [Full Text] [Related]
7. [The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK].
Duckert F; Müller G; Meili EO
Schweiz Med Wochenschr; 1971 Dec; 101(50):1831-8. PubMed ID: 5173501
[No Abstract] [Full Text] [Related]
8. [Long-term follow-up of consumption of plasma, blood and antihemophilic globulin in patients with hemophilia].
Pudlák P; Horák J
Vnitr Lek; 1968 Jan; 15(1):1-8. PubMed ID: 5720983
[No Abstract] [Full Text] [Related]
9. [Substitution therapy of coagulopathies].
Beeser H; Egli H
Infusionstherapie (1973); 1974 Aug; 1(6):447-53. PubMed ID: 4466806
[No Abstract] [Full Text] [Related]
10. [Therapeutic effect on hemophilia by AMCHA].
Gebauer D; Heigel K
Med Klin; 1969 Feb; 64(9):378-82. PubMed ID: 5305740
[No Abstract] [Full Text] [Related]
11. Regimens of factor VIII administration--continuous infusion vs. bolus.
Berntorp E
Haematologica; 2000 Oct; 85(10 Suppl):69-71; discussion 71-2. PubMed ID: 11187875
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of fractures in patients with hemophilia].
Smilowicz M
Wiad Lek; 1970 Apr; 23(7):565-9. PubMed ID: 4917156
[No Abstract] [Full Text] [Related]
13. A study of coagulation factor levels in women during labour and in their newborn infants.
Nossel HL; Lanzkowsky P; Levy S; Mibashan RS; Hansen JD
Thromb Diath Haemorrh; 1966 Jul; 16(1):185-97. PubMed ID: 5989040
[No Abstract] [Full Text] [Related]
14. [Immunosuppressive mechanism and effect of immunoglobulins Anti D and Anti DK (IgG) in the prevention of hemolytic disease of the newborn caused by Rh incompatibility].
Skrzypulec ZA
Zentralbl Gynakol; 1973 Mar; 95(12):402-10. PubMed ID: 4634158
[No Abstract] [Full Text] [Related]
15. Surgical care of patients with hereditary disorders of blood coagulation.
Shulman NR
Mod Treat; 1968 Jan; 5(1):61-83. PubMed ID: 4870180
[No Abstract] [Full Text] [Related]
16. [Pharmacotherapy of hemophilia with the preparation of Lagochilus inebrians BGE].
Akopow IE
Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(1):72-83. PubMed ID: 4104085
[No Abstract] [Full Text] [Related]
17. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography.
Sultan Y; Boyeldieu D; Stieltjes N
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S59-60. PubMed ID: 8177717
[TBL] [Abstract][Full Text] [Related]
18. The use of fraction I for oral surgical procedures in patients with classic hemophilia: report of seven cases.
Marder VJ; Gamble JW; Shulman NR
J Oral Surg; 1966 Nov; 24(6):487-99. PubMed ID: 5296941
[No Abstract] [Full Text] [Related]
19. The use of blood fractions in coagulation disorders.
Biggs R
Br J Haematol; 1969 Dec; 17(6):604. PubMed ID: 5357747
[No Abstract] [Full Text] [Related]
20. Clinical uses of plasma and plasma fractions: plasma-derived products for hemophilias A and B, and for von Willebrand disease.
Josephson CD; Abshire TC
Best Pract Res Clin Haematol; 2006; 19(1):35-49. PubMed ID: 16377540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
